An Evaluation of Fluorouracil plus Paclitaxel and Oxiliplatin as a First-Line Treatment for Advanced Gastric Squamous Cell Carcinoma

OBJECTIVE: To investigate the efficacy of fluorouracil (FU) combined with paclitaxel (PTX) and oxaliplatin (OXA) as the first-line treatment for advanced gastric signet ring cell carcinoma (SRCC) and its influence on human epidermal growth factor receptor 2 (HER-2) expression. METHODS: We collected...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Jie, Shi, Yingpeng, Zheng, Xueli, Lan, Ya, Zhang, Mingxin, Liu, Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101748/
https://www.ncbi.nlm.nih.gov/pubmed/37064950
http://dx.doi.org/10.1155/2023/2176371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101748/
https://www.ncbi.nlm.nih.gov/pubmed/37064950
http://dx.doi.org/10.1155/2023/2176371

Ejemplares similares